000 | 01729 a2200553 4500 | ||
---|---|---|---|
005 | 20250515122810.0 | ||
264 | 0 | _c20090211 | |
008 | 200902s 0 0 eng d | ||
022 | _a1536-4844 | ||
024 | 7 |
_a10.1002/ibd.20492 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnsari, Azhar | |
245 | 0 | 0 |
_aFurther experience with the use of 6-thioguanine in patients with Crohn's disease. _h[electronic resource] |
260 |
_bInflammatory bowel diseases _cOct 2008 |
||
300 |
_a1399-405 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Portal _xchemically induced |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aLiver Function Tests |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRemission Induction _xmethods |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aThioguanine _xadverse effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aElliott, Tim | |
700 | 1 | _aFong, Farina | |
700 | 1 | _aArenas-Hernandez, Monica | |
700 | 1 | _aRottenberg, Giles | |
700 | 1 | _aPortmann, Bernard | |
700 | 1 | _aLucas, Sebastian | |
700 | 1 | _aMarinaki, Anthony | |
700 | 1 | _aSanderson, Jeremy | |
773 | 0 |
_tInflammatory bowel diseases _gvol. 14 _gno. 10 _gp. 1399-405 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ibd.20492 _zAvailable from publisher's website |
999 |
_c18014611 _d18014611 |